| | Publication Year | Title | Author(s) |
| 1 | 3-Sep-2014 | Influence of BDNF Val66Met on the relationship between physical activity and brain volume. | Brown, Belinda M; Bourgeat, Pierrick; Peiffer, Jeremiah J; Burnham, Samantha C; Laws, Simon M; Rainey-Smith, Stephanie R; Bartrés-Faz, David; Villemagne, Victor L ; Taddei, Kevin; Rembach, Alan; Bush, Ashley I; Ellis, Kathryn A; Macaulay, S Lance; Rowe, Christopher C ; Ames, David; Masters, Colin L ; Maruff, Paul; Martins, Ralph N |
| 2 | 12-Mar-2014 | Incidence of cerebral microbleeds in preclinical Alzheimer disease. | Yates, Paul A ; Desmond, Patricia M; Phal, Pramit M; Steward, Christopher; Szoeke, Cassandra; Salvado, Olivier; Ellis, Kathryn A; Martins, Ralph N; Masters, Colin L ; Ames, David; Villemagne, Victor L ; Rowe, Christopher C |
| 3 | 11-Feb-2014 | In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. | Villemagne, Victor L ; Furumoto, Shozo; Fodero-Tavoletti, Michelle T; Mulligan, Rachel S ; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Doré, Vincent ; Yanai, Kazuhiko; Masters, Colin L ; Kudo, Yukitsuka; Rowe, Christopher C ; Okamura, Nobuyuki |
| 4 | 10-Jan-2014 | MR-less surface-based amyloid assessment based on 11C PiB PET. | Zhou, Luping; Salvado, Olivier; Dore, Vincent; Bourgeat, Pierrick; Raniga, Parnesh; Macaulay, S Lance; Ames, David; Masters, Colin L ; Ellis, Kathryn A; Villemagne, Victor L ; Rowe, Christopher C ; Fripp, Jurgen |
| 5 | 2014 | Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. | Rembach, Alan; Watt, Andrew D; Wilson, William J; Villemagne, Victor L ; Burnham, Samantha C; Ellis, Kathryn A; Maruff, Paul; Ames, David; Rowe, Christopher C ; Macaulay, S Lance; Bush, Ashley I; Martins, Ralph N; Masters, Colin L ; Doecke, James D |
| 6 | 1-Dec-2013 | Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. | Rowe, Christopher C ; Bourgeat, Pierrick; Ellis, Kathryn A; Brown, Belinda; Lim, Yen Ying; Mulligan, Rachel S ; Jones, Gareth; Maruff, Paul; Woodward, Michael M ; Price, Roger; Robins, Peter; Tochon-Danguy, Henri; O'Keefe, Graeme J; Pike, Kerryn E; Yates, Paul; Szoeke, Cassandra; Salvado, Olivier; Macaulay, S Lance; O'Meara, Timothy; Head, Richard; Cobiac, Lynne; Savage, Greg; Martins, Ralph N; Masters, Colin L ; Ames, David; Villemagne, Victor L |
| 7 | 20-Nov-2013 | Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). | Ellis, Kathryn A; Szoeke, Cassandra; Bush, Ashley I; Darby, David G; Graham, Petra L; Lautenschlager, Nicola T; Macaulay, S Lance; Martins, Ralph N; Maruff, Paul; Masters, Colin L ; McBride, Simon J; Pike, Kerryn E; Rainey-Smith, Stephanie R; Rembach, Alan; Robertson, Joanne; Rowe, Christopher C ; Savage, Greg; Villemagne, Victor L ; Woodward, Michael M ; Wilson, William; Zhang, Ping; Ames, David |
| 8 | 13-Mar-2013 | Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. | Rembach, Alan; Faux, Noel G; Watt, Andrew D; Pertile, Kelly K; Rumble, Rebecca L; Trounson, Brett O; Fowler, Christopher J; Roberts, Blaine R; Perez, Keyla A; Li, Qiao-Xin; Laws, Simon M; Taddei, Kevin; Rainey-Smith, Stephanie R; Robertson, Joanne S; Vandijck, Manu; Vanderstichele, Hugo; Barnham, Kevin J; Ellis, Kathryn A; Szoeke, Cassandra; Macaulay, S Lance; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Martins, Ralph N; Bush, Ashley I; Masters, Colin L |
| 9 | 8-Mar-2013 | Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. | Villemagne, Victor L ; Burnham, Samantha C; Bourgeat, Pierrick; Brown, Belinda; Ellis, Kathryn A; Salvado, Olivier; Szoeke, Cassandra; Macaulay, S Lance; Martins, Ralph N; Maruff, Paul; Ames, David; Rowe, Christopher C ; Masters, Colin L |
| 10 | 2013 | Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests. | Bahar-Fuchs, Alex; Villemagne, Victor L ; Ong, Kevin; Chetélat, Gaël; Lamb, Fiona ; Reininger, Cornelia B; Woodward, Michael M ; Rowe, Christopher C |
| 11 | 23-Oct-2012 | Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. | Verdile, G; Laws, Simon M; Henley, D; Ames, David; Bush, Ashley I; Ellis, Kathryn A; Faux, N G; Gupta, V B; Li, Q-X; Masters, Colin L ; Pike, Kerryn E; Rowe, Christopher C ; Szoeke, Cassandra; Taddei, K; Villemagne, Victor L ; Martins, Ralph N |
| 12 | 8-Mar-2012 | Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. | Villemagne, Victor L ; Mulligan, Rachel S ; Pejoska, Svetlana; Ong, Kevin; Jones, Gareth; O'Keefe, Graeme J; Chan, J Gordon ; Young, Kenneth ; Tochon-Danguy, Henri; Masters, Colin L ; Rowe, Christopher C |
| 13 | 15-Jul-2011 | Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. | Villemagne, Victor L ; Ong, Kevin; Mulligan, Rachel S ; Holl, Gerhard; Pejoska, Svetlana; Jones, Gareth; O'Keefe, Graeme J; Ackerman, Uwe; Tochon-Danguy, Henri; Chan, J Gordon ; Reininger, Cornelia B; Fels, Lueder; Putz, Barbara; Rohde, Beate; Masters, Colin L ; Rowe, Christopher C |
| 14 | 1-Jul-2011 | In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. | Villemagne, Victor L ; Okamura, Nobuyuki; Pejoska, Svetlana; Drago, John; Mulligan, Rachel S ; Chételat, Gaël; Ackermann, Uwe ; O'Keefe, Graeme J; Jones, Gareth; Gong, Sylvia J; Tochon-Danguy, Henry; Kung, Hank F; Masters, Colin L ; Skovronsky, Daniel M; Rowe, Christopher C |
| 15 | 16-Apr-2011 | Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. | Pike, Kerryn E; Ellis, Kathryn A; Villemagne, Victor L ; Good, Norm; Chételat, Gael; Ames, David; Szoeke, Cassandra; Laws, Simon M; Verdile, Giuseppe; Martins, Ralph N; Masters, Colin L ; Rowe, Christopher C |
| 16 | 9-Feb-2011 | Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. | Chételat, Gaël; Villemagne, Victor L ; Pike, Kerryn E; Ellis, Kathryn A; Bourgeat, Pierrick; Jones, Gareth; O'Keefe, Graeme J; Salvado, Olivier; Szoeke, Cassandra; Martins, Ralph N; Ames, David; Masters, Colin L ; Rowe, Christopher C |
| 17 | 15-May-2010 | Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. | Rowe, Christopher C ; Ellis, Kathryn A; Rimajova, Miroslava; Bourgeat, Pierrick; Pike, Kerryn E; Jones, Gareth; Fripp, Jurgen; Tochon-Danguy, Henri; Morandeau, Laurence; O'Keefe, Graeme J; Price, Roger; Raniga, Parnesh; Robins, Peter; Acosta, Oscar; Lenzo, Nat; Szoeke, Cassandra; Salvado, Olivier; Head, Richard; Martins, Ralph N; Masters, Colin L ; Ames, David; Villemagne, Victor L |
| 18 | 9-Feb-2010 | 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. | Ly, J V; Donnan, Geoffrey A ; Villemagne, Victor L ; Zavala, J A; Ma, Henry K; O'Keefe, Graeme J; Gong, Sylvia J; Gunawan, R M; Saunder, T; Ackermann, Uwe ; Tochon-Danguy, Henri; Churilov, Leonid ; Phan, T G; Rowe, Christopher C |
| 19 | 15-Jan-2010 | In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. | Okamura, Nobuyuki; Villemagne, Victor L ; Drago, John; Pejoska, Svetlana; Dhamija, Rajinder K; Mulligan, Rachel S ; Ellis, Julia R; Ackermann, Uwe ; O'Keefe, Graeme J; Jones, Gareth; Kung, Hank F; Pontecorvo, Michael J; Skovronsky, Daniel; Rowe, Christopher C |
| 20 | 2010 | Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study. | Bahar-Fuchs, Alex; Chételat, Gael; Villemagne, Victor L ; Moss, Simon; Pike, Kerryn E; Masters, Colin L ; Rowe, Christopher C ; Savage, Greg |